Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?

Citeline Podcasts - En podcast af Citeline

Podcast artwork

Kategorier:

Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Alan Minsk of Arnall Golden Gregory, as well as Naya Therapeutics CEO Daniel Teper

Visit the podcast's native language site